High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$1.8M
$1,770,000
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
REGN
M
REGENERON PHARMACEUTICALS, INC.
Bassler Bonnie L
• Director
Equity Compensation
2026-01-07
$561,180x2
|
||||||
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
Equity Compensation
|
2026-01-07 | $561,180x2 | M | Form 4 |
|
REGN
S
REGENERON PHARMACEUTICALS, INC.
Bassler Bonnie L
• Director
10b5-1 SellΔOwn -46.8%
2026-01-07
$1,200,000Large
|
||||||
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 SellΔOwn -46.8%
|
2026-01-07 | $1,200,000Large | S | Form 4 |
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
Other
|
2025-11-20 | $282,264 | M | Form 4 |
|
REGN
S
REGENERON PHARMACEUTICALS, INC.
Bassler Bonnie L
• Director
10b5-1 SellΔOwn -32.9%
2025-11-20
$570,000
|
||||||
| REGN |
REGENERON PHARMACEUTICALS, INC.
|
Director
10b5-1 SellΔOwn -32.9%
|
2025-11-20 | $570,000 | S | Form 4 |